Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Structure Therapeutics Inc. - American Depositary Shares (NQ: GPCR ) 40.27 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Structure Therapeutics Inc. - American Depositary Shares < Previous 1 2 3 4 Next > Cava Stock Makes A Stand In Mixed IPO Landscape: Where Does It Rank Against Other 2023 Wall Street Debuts? June 16, 2023 In a year that’s seen a sharp decline in initial public offerings, Washington, D.C.-based Mediterranean restaurant chain Cava Group (NYSE: CAVA) made a striking first public appearance on the New York... Via Benzinga This Biotech Is Developing The Next Ozempic. Should You Buy It? June 16, 2023 If it succeeds, it'll still face a battle for market share. Via The Motley Fool Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 Years June 12, 2023 If you can tolerate the risk and have some patience, both stocks could blossom. Via The Motley Fool Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions June 07, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics to Present at Jefferies Healthcare Conference May 31, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 26, 2023 Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. Via Benzinga Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday May 26, 2023 U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity May 25, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference May 18, 2023 Posters include data across biomarker, translation and clinical studies supporting development of cardiopulmonary programs LTSE-2578 and ANPA-0073 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights May 11, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights March 30, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race February 28, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 February 28, 2023 Via Benzinga There's a Lot to Love About Mineralys' Valentine's Day IPO February 13, 2023 MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million Via MarketBeat Topics Initial Public Offering Exposures Securities Market Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares February 07, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development February 04, 2023 Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a... Via Talk Markets Dow Drops Over 150 Points; US economy Adds 517,000 Jobs In January February 03, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.51% to 33,881.69 while the NASDAQ fell 1.32% to 12,039.79. The S&P 500 also fell, dropping, 0.98%... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.